发明名称 Xanthine derivatives for the treatment of cerebrovascular disorders
摘要 <p>A method for the treatment of cerebrovascular disorders and/or disorders associated with cerebral senility and/or other disorders which method comprises the administration of an effective, non-toxic amount of a compound of formula (I): &lt;CHEM&gt; or if appropriate a pharmaceutically acceptable salt thereof, wherein R&lt;1&gt; and R&lt;2&gt; each independently represent alkyl or a moiety of formula (a): -(CH2)m-A wherein m represents zero or an integer 1, 2 or 3; A represents a substituted or unsubstituted cyclic hydrocarbon radical; and R&lt;3&gt; represents a halogen atom, a nitro group, or a group -NR&lt;4&gt;R&lt;5&gt; wherein R&lt;4&gt; and R&lt;5&gt; each independently represents hydrogen, alkyl or alkylcarbonyl or R&lt;4&gt; and R&lt;5&gt; together with the nitrogen to which they are attached forming an optionally substituted, heterocyclic group; certain novel compounds falling within formula (I) and compositions comprising such compounds.</p>
申请公布号 EP1120417(A2) 申请公布日期 2001.08.01
申请号 EP20000203905 申请日期 1990.03.22
申请人 SMITHKLINE BEECHAM PHARMA GMBH;BEECHAM GROUP PLC 发明人 MASCHLER, HARALD;SPICER, BARBARA ANN;SMITH, HARRY
分类号 C07D473/04;A61K31/52;A61K31/522;A61K31/535;A61K31/5377;A61P9/00;A61P9/08;A61P9/10;A61P11/00;A61P25/00;A61P25/28;A61P37/08;C07D239/545;C07D473/06;C07D473/08;(IPC1-7):C07D473/06 主分类号 C07D473/04
代理机构 代理人
主权项
地址